Bangalore Bioinnovation Centre (BBC) has won the prestigious title of ‘Most Innovative Bioinnovation Centre' at the Outlook Business Awards 2023. The event was organized by Outlook Business to recognize and celebrate excellence in business innovation, creativity, and leadership. Professionals and leaders from different industries attended the event.
Bangalore Bioinnovation Centre (BBC) is a Technology Business Incubator supported by the Department of Electronics, IT, BT and S&T, Government of Karnataka, Department of Biotechnology (DBT), Government of India. It is a cutting-edge translational research and entrepreneurship centre that serves the demands of modern life sciences start-ups. Within a short period of existence, it has reached 100% occupancy and is supporting numerous start-ups in creating new goods and technologies with significant societal effects. A fully functional Central Instrumentation Facility (CIF) is available at BBC to serve the multidisciplinary research requirements of entrepreneurs in the various fields of the life sciences. BBC houses around 100 Incubatees. BBC has graduated 55 incubatees. At BBC, 71 patent applications have been filed.
Dr Jitendra Kumar is the Director of Bangalore Bioinnovation Centre (BBC). He has around 20 years of expertise in managing innovation and research in the biological sciences. About 45 products are developed and launched under his mentorship, and he has around 30 publications that have undergone peer review.
“Bangalore Bioinnovation Centre (BBC) is incredibly grateful to have won this prize. For the team, it is undoubtedly one of the best experiences. BBC is fortunate to have won this prize and will keep striving for excellence. This accolade will motivate and inspire the team to enhance their work.”, he said.
The Centre's key goals include supporting and mentoring companies. As a team, BBC assists startups in developing their technology by understanding their needs. BBC provides them with top-notch facilities to conduct their research. They offer a plug-and-play paradigm, which makes it simpler for entrepreneurs to access the equipment and expand their research. They also make sure that companies innovate and perform exceptionally well in their research with ease. For internal users and visitors, BBC provides bench space as well as big and small incubation suites. Nurturing their incubatees in all possible aspects has helped BBC to excel.
Some of the most inspiring innovations done at BBC are:
● Remote foetal monitoring device (Daksh) by Janitri Innovations Private Limited- useful for Covid-19 positive pregnant women. This device helps remote monitoring of the foetus and protects doctors and hospital staff against Covid 19.
● VNIR Biotechnologies Pvt Ltd. has created fluorescent probes and a PCR mixture for RT-PCR detection.
● Cov-Astra by Aindra Systems Private limited- An AI-based device for detection of Covid-19. It detects Covid-19 virus using X-ray.
● Vyvuz – A herbal formulation by Atrimed Biotech LLP to prevent COVID-19 infections for those who have exposure to primary contacts.
● Engineered Enzymes for Bio-catalysis applications by KCat- An AI based enzyme engineering framework to engineer 07 enzymes that are now used in production of pharmaceutical drugs and nutraceuticals. These enzymes allow mild working conditions compared to traditional chemical catalysts making it eco-friendly, and cost-effective.
● Neuheart by Neuome Technologies- A cardiac illness detection kit.
● Oncodx by Archeron Innovations Pvt Ltd- An early stage cancer diagnostic kit using Crisper Cas technology.
● NucleoDx RT by NeoDx- A simple and cost effective method of RNA isolation used in RT PCR for detection of COVID 19. This is developed indigenously.
● Intelligent Vision Analyser (iVA) by Alphaleus- A virtual reality based device that performs eye tests like visual field test, contrast sensitivity, eye mobility test and visual acuity. This device can easily be sanitised using an alcohol swab or UV chamber.
● TARGT Indiegene by 4Basecare- India’s largest and first population specific tumor gene panel derived from WES/WTS data over 1500 cancer patients across 28 different cancer types. This supports oncologists in precision medicine practice.